NTRA: Natera Medical Market Value

Corporate emblem and logo of Natera (NTRA)

The market value dynamics of Natera, Inc. (NTRA) on the GURU.Markets platform, which currently stands at 46.06, illustrate the company's success in the reproductive health sector. Management is rapidly expanding its presence in the genetic testing niche, investing in research to achieve exponential sales growth. Expert management has ensured the transition from a loss-making startup to profitable leadership, while a high pace of innovation guarantees shareholder confidence.

Natera - NTRA Market Capitalization (period 07/04/2022 - 11/14/2026)

NTRA (Natera Medical): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Quotes Natera|NTRA - Analyst Forecast Prices
- market capitalization information:
Market Value Natera Medical|NTRA - Value Adjusted for Debt and Cash
- book value of equity indicators:
Book Value per Share Natera|NTRA - Book Capitalization|Market Value to Book Value Ratio natera.com|NTRA - Aggregate Asset Value
- debt and solvency information:
Total Debt to Capital Natera, Inc.|NTRA - Long-Term Liabilities to Capital|Short-Term Debt to Equity Natera, Inc.|NTRA - Company Aggregate Indebtedness|Debt to Book Capitalization Ratio Natera Medical|NTRA - Company Long-Term Loans and Borrowings|Company Short-Term Debt Natera|Quick Ratio natera.com
- financial results and valuation multiples details:
NTRA - Company Profit|Future Profit Natera, Inc.|NTRA - P/E Multiple|Forward P/E Multiple Natera Corp|NTRA - Price/Earnings to Growth Multiple|Enterprise Value to EBITDA Ratio Natera Medical|NTRA - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) Natera|NTRA - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months natera.com|NTRA - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Natera, Inc.
- total revenue and sales volume data:
NTRA - Company Sales Volume|Company Projected Revenue Natera|NTRA - Market Cap to Revenue Ratio|Forward P/S Multiple Natera Medical
Fundamental valuation:NTRA (Natera)
Product sample of Natera, Inc.

Market capitalization reflects the aggregate value of all shares, converting exchange demand into an objective indicator of a business's fundamental stability. By analyzing the market valuation dynamics of Natera, Inc. (NTRA), an investor can see how the rapid adoption of genetic tests and revenue growth translate into capital, allowing them to filter out information noise and assess the actual level of confidence in management.

Key competitors

Humacyte - Market Valuation|Market Value SERA (Sera Prognostics Inc.)